Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.28 +0.00 (+0.00%)
As of: Aug 21, 2026 · 1:56 PM EDT

Creative Medical Technology Holdings (CELZ) Operating Margin Growth (5y) (2022 - 2025)

Creative Medical Technology Holdings (CELZ) Operating Margin Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.50 Bn 131.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.10 Bn 78.10 Bn 3.93 Bn
3 Argenx Se 65.59 Bn 60.41 Bn 1.37 Bn
4 Moderna 56.75 Bn 51.62 Bn 52.00 Mn
5 BeOne Medicines 42.11 Bn 37.01 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.64 Bn 28.33 Bn 992.69 Mn
7 BioNTech SE 27.80 Bn 9.41 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.45 Bn -
10 Creative Medical Technology Holdings 1.83 Mn 1.83 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.30 Mn
Mar 31, 2025 -5.46 Mn
Dec 31, 2024 -7.04 Mn
Jun 30, 2024 -1.99 Mn
Dec 31, 2023 -5.85 Mn
Sep 30, 2023 -2.52 Mn
Dec 31, 2022 -2.86 Mn